UK markets close in 1 hour 42 minutes

Fresenius Medical Care AG (FMCQF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
41.900.00 (0.00%)
As of 11:46AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 12.29B
Enterprise value 23.56B
Trailing P/E 23.02
Forward P/E 12.09
PEG ratio (5-yr expected) 0.45
Price/sales (ttm)0.59
Price/book (mrq)0.84
Enterprise value/revenue 1.21
Enterprise value/EBITDA 7.34

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-9.81%
S&P500 52-week change 323.10%
52-week high 349.86
52-week low 334.33
50-day moving average 339.33
200-day moving average 341.27

Share statistics

Avg vol (3-month) 3106
Avg vol (10-day) 3200
Shares outstanding 5293.41M
Implied shares outstanding 6297.14M
Float 8198.94M
% held by insiders 132.17%
% held by institutions 138.92%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.28
Forward annual dividend yield 43.06%
Trailing annual dividend rate 31.19
Trailing annual dividend yield 32.84%
5-year average dividend yield 41.30
Payout ratio 465.88%
Dividend date 3N/A
Ex-dividend date 417 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 2.57%
Operating margin (ttm)9.93%

Management effectiveness

Return on assets (ttm)2.73%
Return on equity (ttm)4.84%

Income statement

Revenue (ttm)19.45B
Revenue per share (ttm)66.30
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)N/A
EBITDA 2.38B
Net income avi to common (ttm)499M
Diluted EPS (ttm)1.82
Quarterly earnings growth (yoy)35.40%

Balance sheet

Total cash (mrq)1.56B
Total cash per share (mrq)5.31
Total debt (mrq)12.05B
Total debt/equity (mrq)81.28%
Current ratio (mrq)1.42
Book value per share (mrq)46.42

Cash flow statement

Operating cash flow (ttm)2.63B
Levered free cash flow (ttm)1.33B